Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study

Bibliographic Details
Main Authors:	Kim, Jong-Min, Chung, Sun Ju, Kim, Jae Woo, Jeon, Beom Seok, Singh, Pritibha, Thierfelder, Stephan, Ikeda, Junji, Bauer, Lars
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364324/

Similar Items

Transdermal Patch of Rotigotine Attenuates Freezing of Gait in Patients with Parkinson's Disease: An Open-Label Comparative Study of Three Non-Ergot Dopamine Receptor Agonists
by: Ikeda, Ken, et al.
Published: (2016)

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
by: Kim, Han-Joon, et al.
Published: (2011)

Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism
by: Moretti, Davide Vito, et al.
Published: (2014)

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
by: Hauser, Robert A, et al.
Published: (2016)

Transdermal rotigotine for the perioperative management of restless legs syndrome
by: Högl, Birgit, et al.
Published: (2012)

Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
by: Cawello, Willi, et al.
Published: (2013)

Dropped head sign induced by transdermal application of the dopamine agonist rotigotine in parkinsonian syndrome: a case report
by: Dohm, Christoph P, et al.
Published: (2013)

Rotigotine Transdermal Patch in Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Zhou, Chang-Qing, et al.
Published: (2013)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
by: Miguel Rosa-Grilo, et al.
Published: (2017-09-01)

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke
by: Gorgoraptis, Nikos, et al.
Published: (2012)

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
by: LeWitt, Peter A., et al.
Published: (2012)

Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study
by: Kassubek, Jan, et al.
Published: (2014)

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome
by: Elshoff, Jan-Peer, et al.
Published: (2015)

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
by: Pagonabarraga, Javier, et al.
Published: (2015)

Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis
by: Giladi, Nir, et al.
Published: (2016)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
by: Reichmann, Heinz
Published: (2009)

Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording
by: Calandra-Buonaura, Giovanna, et al.
Published: (2016)

Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease
by: Vallderiola, Francesc, et al.
Published: (2015)

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
by: LeWitt, Peter A., et al.
Published: (2016)

Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage
by: Giladi, Nir, et al.
Published: (2016)

Causes and factors related to dopamine agonist withdrawal in Parkinson′s disease
by: Castro, Ester Suárez, et al.
Published: (2016)

Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
by: Zhang, Jinglin, et al.
Published: (2016)

EHMTI-0081. Use of rotigotine in chronic cluster headache
by: Savi, L, et al.
Published: (2014)

Dopamine Agonists and Pathologic Behaviors
by: Kelley, Brendan J., et al.
Published: (2012)

Dopamine Agonists for Pituitary Adenomas
by: Odelia Cooper, et al.
Published: (2018-08-01)

Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy
by: Moretti, Davide Vito, et al.
Published: (2014)

Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
by: Bi, Chenchen, et al.
Published: (2016)

Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT
by: Bauer, Axel, et al.
Published: (2016)

Dopamine Receptors and Parkinson's Disease
by: Hisahara, Shin, et al.
Published: (2011)

Hypothesis: Somatic Mosaicism and Parkinson Disease
by: Kim, Han-Joon, et al.
Published: (2014)

Parkinsonism in Spinocerebellar Ataxia
by: Park, Hyeyoung, et al.
Published: (2015)

Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease
by: Lhommée, Eugénie, et al.
Published: (2014)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
by: Arbouw, Maurits E. L., et al.
Published: (2011)

Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation
by: Bandettini di Poggio, Monica, et al.
Published: (2013)

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis
by: Thorlund, Kristian, et al.
Published: (2014)

The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study
by: Pellicano, Clelia, et al.
Published: (2013)

Dopamine Agonists Exert Nurr1-inducing Effect in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease
by: Zhang, Li-Min, et al.
Published: (2015)

Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology
by: Borovac, Josip Anđelo
Published: (2016)

Impulse control disorder related behaviours during long‐term rotigotine treatment: a post hoc analysis
by: Antonini, A., et al.
Published: (2016)

The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
by: Hori, Hiroaki, et al.
Published: (2012)